Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism
Arthur L. Burnett(Johns Hopkins University), Biljana Musicki(Johns Hopkins University), Trinity J. Bivalacqua(University of Pennsylvania), Hunter C. Champion(Southeastern University)
Cited by 144
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
|The Journal of Urology|2007|1.1k
Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
|The Journal of Urology|2007|845
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683
Pulmonary Hypertension Due to Left Heart Diseases
|Journal of the American College of Cardiology|2013|635